Mounjaro coupons & savings
tirzepatide · manufacturer programs, telehealth bundles, discount cards
Jump to section
Mounjaro is FDA-approved for type 2 diabetes. Lilly's commercial savings card offers significant cost reduction for insured T2D patients.
Your options
- Manufacturer
Mounjaro Savings Card
as low as $25/monthEligibility: T2D diagnosis + commercial insurance that covers Mounjaro. Not eligible for Medicare, Medicaid, federal programs.
- Discount card
GoodRx coupon
~$995/monthEligibility: No eligibility restrictions.
Important notes
- Mounjaro is for diabetes; weight-loss patients should look at Zepbound (same active ingredient, weight-loss indication).
- Off-label Mounjaro for weight loss is generally not covered by insurance.
Mounjaro and Zepbound are the same drug — the price split is about the label
Mounjaro and Zepbound are both tirzepatide, made by Eli Lilly. The difference is the FDA-approved indication: Mounjaro is approved for type 2 diabetes, Zepbound for chronic weight management (and now obstructive sleep apnea). That labeling split is what determines your cheapest path, because insurers cover the on-label use.
If you have type 2 diabetes, Mounjaro is the version your plan is likely to cover, and coverage is your cheapest route. If your goal is weight loss, Zepbound is the on-label version with weight-loss savings programs (including LillyDirect self-pay vials) — pursuing Mounjaro off-label for weight loss usually means no coverage and a higher bill for the identical molecule.
If you have type 2 diabetes: how to get Mounjaro cheapest
Start with coverage. Commercial plans generally cover Mounjaro for diabetes, and Lilly offers a Mounjaro savings card for commercially insured, covered patients that can substantially cut the copay — subject to the same kind of introductory-then-higher structure and federal-exclusion rules as other manufacturer cards. Medicare and Medicaid patients cannot use the card but usually have diabetes coverage through their plan.
Check your formulary tier and prior-authorization requirement; tirzepatide often needs a PA form your prescriber submits. If coverage is denied, a discount card trims only a little off the high branded list price (around $995 retail) — appeal first if you have the diagnosis.
Off-label for weight loss: the expensive mismatch
Using Mounjaro off-label to lose weight is typically the most expensive way to take tirzepatide: the off-label use is rarely covered, and you cannot access the weight-management savings programs that exist for Zepbound. Since it is literally the same active ingredient, there is no efficacy reason to pay more for the diabetes label.
The cost-smart move for a weight-loss goal is to ask a prescriber about Zepbound, which has both an on-label coverage pathway and the LillyDirect self-pay vial route. Same drug, a savings ecosystem that actually applies to you.
More on Mounjaro
Frequently asked
What's the cheapest way to get Mounjaro?+
Based on the programs currently tracked, the lowest sticker price for Mounjaro is "Mounjaro Savings Card" at as low as $25/month. Eligibility varies by program — check the requirements for each option above before counting on a price.
Does insurance cover Mounjaro?+
Insurance coverage for Mounjaro depends on the plan and indication. Many commercial plans cover tirzepatide for FDA-approved uses with prior authorization; off-label use is rarely covered. Check your formulary or run your plan through our insurance coverage tool.
Are coupons for Mounjaro legitimate?+
Manufacturer programs from Mounjaro's maker and federally registered patient assistance foundations are legitimate. Be cautious with discount cards that promise prices far below retail without verifying the dispensing pharmacy is licensed in your state.
What's the best option for Mounjaro right now?+
Editorial pick: Mounjaro Savings Card at as low as $25/month. T2D diagnosis + commercial insurance that covers Mounjaro. Not eligible for Medicare, Medicaid, federal programs. This is a starting point; your situation may favor a different program based on insurance and clinical eligibility.